Dr. Reddy's Laboratories Limited
NYSE:RDY · New York Stock Exchange
-$0.15 today
Vol 1.33M · Avg 2.39M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-12.74%
Period High
$15.51
Period Low
$12.46
Latest
$13.29
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Revolution Medicines, Inc.
NASDAQ:RVMD
$33.54B
Viatris Inc.
NASDAQ:VTRS
$18.32B
Neurocrine Biosciences, Inc.
NASDAQ:NBIX
$15.99B
Exelixis, Inc.
NASDAQ:EXEL
$13.18B
Solventum Corporation
NYSE:SOLV
$12.91B
Elanco Animal Health Incorporated
NYSE:ELAN
$11.68B
Revvity, Inc.
NYSE:RVTY
$10.91B
BioMarin Pharmaceutical Inc.
NASDAQ:BMRN
$10.63B
Encompass Health Corporation
NYSE:EHC
$9.71B
The Ensign Group, Inc.
NASDAQ:ENSG
$9.11B
What is the latest RDY filing?
The latest filing shown is 6-K dated Jun 15, 2026.
How many recent filings does RDY have?
Intrinsic Alpha currently shows 20 recent filings for RDY.
Explore More
Continue the stock analysis
Jump to another research area for this company.